FDA OK for Gaucher drug opens new market for Pfizer, Protalix – FierceBiotech

FDA OK for Gaucher drug opens new market for Pfizer, Protalix
FierceBiotech
After initially being rebuffed at the FDA Pfizer ($PFE) and Protalix have snagged an FDA OK for their new Gaucher disease drug Elelyso (taliglucerase), an orphan enzyme replacement therapy which will appear on the market at a discount over Genzyme's …
FDA approves new drug for GaucherFox News
Pfizer Takes on Genzyme With New Gaucher DrugXconomy
Elelyso Approved to Treat a Form of Gaucher DiseaseKansas City infoZine
Technorati -Bloomberg -FDA.gov
all 69 news articles »